According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

Cendakimab fell short of the bar. The antibody hits IL-13, one of the interleukins targeted by Regeneron and Sanofi’s ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Secret Lives of Mormon Wives star Mikayla Matthews shared a post on Instagram, in which she gave an update on her journey ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...

We recently published a list of 10 Best Falling Stocks to Invest in Right Now. In this article, we are going to take a look ...

The initial symptoms of anaphylaxis can overlap with those of a common reaction called immediate post-injection reaction that is temporary and can start soon after a shot is given. While immediate ...

At three days post-surgery, she gave all the details of her augmentation ... Getty 'DWTS' Alum Lindsay Arnold on Expecting Again After Her Recent Pregnancy Struggles: 'Trust Your Body' She ...

The Business Research Company's The Dupixent Global Market Report: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034 It will grow to $XX million in 2029 ...

Share on Pinterest “Before my husband Tom and I had a baby ... on to write a book entitled “How Not to Hate Your Husband After Kids.” If either part of Dunn’s story sounds familiar ...